Phytonadione - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for phytonadione and what is the scope of patent protection?
Phytonadione
is the generic ingredient in five branded drugs marketed by Pai Holdings Pharm, Roche, Cipla, Dr Reddys, Glaxosmithkline, Intl Medication, Hospira, Bausch, Agnitio, Amneal Pharms Co, Sciegen Pharms Inc, and Zydus Lifesciences, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for phytonadione. Seventeen suppliers are listed for this compound.
Summary for phytonadione
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 12 |
NDAs: | 15 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 7 |
Patent Applications: | 5,478 |
Drug Prices: | Drug price trends for phytonadione |
What excipients (inactive ingredients) are in phytonadione? | phytonadione excipients list |
DailyMed Link: | phytonadione at DailyMed |
Recent Clinical Trials for phytonadione
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Sydney | Phase 3 |
Australasian Kidney Trials Network | Phase 3 |
Waitemata District Health Board | Phase 3 |
Pharmacology for phytonadione
Drug Class | Vitamin K Warfarin Reversal Agent |
Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
US Patents and Regulatory Information for phytonadione
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 084060-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dr Reddys | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 207719-001 | May 22, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cipla | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 214596-001 | Apr 22, 2022 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cipla | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 214596-002 | Apr 22, 2022 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.